Centerline Biomedical and ORSIF join together to raise
awareness of health risks associated with fluoroscopic radiation
and solutions available to medical professionals.
CLEVELAND, July 9, 2024
/PRNewswire/ -- Centerline Biomedical, Inc. ("Centerline"),
joins ORSIF, the organization for Occupational Radiation Safety in
International Fluoroscopy, to raise awareness of technology options
to improve safety in the work environment where fluoroscopic x-ray
radiation is used in medical procedures. As a corporate partner,
Centerline supports ORSIF (www.orsif.org) in a shared mission to
champion innovation for safer healthcare. In addition, the
developing platform aims to continue bringing together healthcare
providers and their organizations, professional medical societies,
and industry to provide education on radiation safety.
"We are proud to join ORSIF in its mission to create greater
awareness in the medical community regarding the dangers of
radiation exposure and to protect those who commit their lives to
the wellness of others. To that end, IOPS®
(Intra-Operative Positioning System) technology enables improved
visualization with 3D navigation in endovascular procedures while
minimizing the reliance on damaging radiation," said Gulam Khan, CEO of Centerline Biomedical.
"Employees at Centerline are inspired every day to design the
future of image guidance technology that enables faster, more
precise transcatheter procedures while reducing the use of
radiation."
Designed to mitigate radiation exposure during minimally
invasive cardiovascular procedures, Centerline Biomedical IOPS
(Intra-Operative Positioning System) is a novel technology gaining
increased application in the US. IOPS includes software that
creates 3D maps of vascular anatomy, enabling surgeons to visualize
the arteries being treated. Using electromagnetic tracking, IOPS
sensor-equipped guidewires and catheters can be guided in 3D as
endovascular specialists navigate through these high-resolution
intuitive visualizations during minimally invasive procedures. The
images and tracking are displayed on an independent monitor,
minimizing the reliance on damaging X-ray radiation typically used
to produce live fluoroscopic images during interventions.
About Centerline Biomedical
Founded in 2015,
Centerline Biomedical is headquartered in Cleveland,
Ohio. The company's commercially
available platform, IOPS®, Intra-Operative Positioning
System, enables improved visualization and navigation in
endovascular procedures. IOPS has 510(k) clearance from the US FDA
for use in the descending aorta. The company continues investment
in development to enhance the current technology platform and
expand image guidance in transcatheter procedure applications.
Visit www.centerlinebiomedical.com for more
information.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/centerline-biomedical-joins-orsif-302192349.html
SOURCE Centerline Biomedical